Approval for a minor design change to modify the advancer tube to incorporate a dual slit design at the proximal end of the advancer tube.  The device, as modified, will be marketed under the trade name mynx cadence vascular closure device and is indicated for use to seal femoral arterial access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5f, 6f or 7f procedural sheath.